Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.

Digestive diseases and sciences - 1 Jan 2016

Findlay John M, Middleton Mark R, Tomlinson Ian

Abstract excerpt

Barrett's esophagus (BE) is a common and important precursor lesion of esophageal adenocarcinoma (EAC). A third of patients with BE are asymptomatic, and our ability to predict the risk of progression of metaplasia to dysplasia and EAC (and therefore guide management) is limited. There is an urgent need for clinically useful biomarkers of susceptibility to both BE and risk of subsequent progression. This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Barrett Esophagus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Esophageal Neoplasms

Share to Esophagus

Share to Precancerous Conditions

Share to Risk Assessment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 26445852
DOI: 10.1007/s10620-015-3884-5
PMCID: PMC4700058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.PMID 26445852Read ↗

Molecular Abnormalities and Carcinogenesis in Barrett’s Esophagus: Implications for Cancer Treatment and PreventionSemantic proximity Read ↗

The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus.Semantic proximity Read ↗

Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.Semantic proximity Read ↗

The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.Semantic proximity Read ↗

Epigenetic biomarkers in esophageal cancer.Semantic proximity Read ↗

Molecular Biology of Barrett’s AdenocarcinomaSemantic proximity Read ↗

Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus.Semantic proximity Read ↗

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Barrett’s Esophagus and Esophageal AdenocarcinomaSemantic proximity Read ↗

Genetic Profiles of Barrett’s Esophagus and Esophageal Adenocarcinoma in Japanese patientsSemantic proximity Read ↗

Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.Semantic proximity Read ↗

Genomics of Esophageal Cancer and Biomarkers for Early Detection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.